Invesco
ALBO

Invesco’s Albireo Pharma Inc ALBO Stock Holding History

Invesco’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,780
Closed -$203K – 4199
2022
Q1 		$203K Buy
+6,780
New +$198K ﹤0.01% 3770
2021
Q4 		– Sell
-7,132
Closed -$223K – 4127
2021
Q3 		$223K Buy
7,132
+1,304
+22% +$40.3K ﹤0.01% 3766
2021
Q2 		$205K Buy
+5,828
New +$189K ﹤0.01% 3783
2020
Q4 		– Sell
-25,024
Closed -$835K – 3851
2020
Q3 		$835K Buy
+25,024
New +$729K ﹤0.01% 2901

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Invesco's ALBO Position: Q2 2022 in Review

Invesco sold out of Albireo Pharma Inc (ALBO) in Q2 2022, closing a stake of 6,780 shares — an estimated $203K sold.

Invesco first reported a position in ALBO in Q3 2020 and held it in 4 quarters. The position peaked at $835K in Q3 2020. 103 funds tracked by Wall St. Rank hold ALBO as of Q2 2022.

  • Invesco reported no remaining Albireo Pharma Inc position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 6,780 Albireo Pharma Inc shares in Q2 2022, an estimated $203K.
  • Invesco first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 4 quarters.
  • Invesco's Albireo Pharma Inc position peaked at $835K in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.